Massimo Ambrosini

I'm Massimo, an entrepreneur and scientist working at the intersection of bioengineering and deep-tech innovation. My conviction is simple: the hardest problems in human health demand bold, cross-disciplinary solutions built from first principles.

At the core of my current work is 3DScreen — a pioneering initiative developing the world's first 3D human physiological disease models for Type 2 Diabetes and Obesity. Using a novel combination of ultrasound-based patterning and synthetic biomaterials, we engineer living, human-relevant tissue models with a fidelity that 2D cultures and animal models cannot match. The impact is transformative: faster drug discovery, fewer animal trials, and a new foundation for tackling two of the most pressing metabolic epidemics of our time.

3DScreen is being built within the innovation ecosystem of ETH Zürich and is proudly supported by Innosuisse, the Swiss Innovation Agency — a combination of research excellence and translational backing that gives us a uniquely strong platform to move from breakthrough to deployment.

I'm at the Global Innovation Summit to connect with builders, scientists, and partners who share that ambition.